OR10Q1 inhibitors are chemical compounds that target and inhibit the activity of the olfactory receptor OR10Q1, which belongs to the G-protein-coupled receptor (GPCR) superfamily. OR10Q1 is part of a large and diverse family of olfactory receptors that play a role in detecting and processing odorant molecules, a fundamental aspect of the olfactory system in humans and animals. GPCRs, including OR10Q1, transduce extracellular signals into intracellular responses through the interaction with G-proteins, which initiate a cascade of signaling events within the cell. By inhibiting OR10Q1, these chemical compounds prevent the receptor from binding to its specific ligands, thereby modulating the olfactory signaling pathway that would normally be triggered by those interactions.
Structurally, OR10Q1 inhibitors often contain functional groups designed to specifically interact with key residues in the ligand-binding domain of the receptor, preventing its activation. The inhibitors may be characterized by their selective binding affinities, which allow them to specifically target OR10Q1 without affecting other olfactory or GPCR receptors. This selectivity is crucial in ensuring precise modulation of OR10Q1-related signaling pathways, which are involved in more than just olfactory perception, as OR10Q1 can be expressed in various tissues. Research into OR10Q1 inhibitors often focuses on their molecular docking properties, structure-activity relationships, and the biochemical pathways they influence. The inhibition of OR10Q1 provides insights into receptor function, the broader olfactory signaling mechanism, and the chemical specificity underlying receptor-ligand interactions. These studies contribute to a deeper understanding of molecular recognition and signaling transduction within the GPCR family.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin might downregulate OR10Q1 expression by inhibiting the activation of NF-κB, a transcription factor that could be involved in the transcriptional initiation of the OR10Q1 gene. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol could decrease OR10Q1 expression by elevating the levels of sirtuins that deacetylate histones associated with the OR10Q1 promoter region, leading to a more condensed chromatin state and reduced transcription. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG may reduce OR10Q1 expression by altering DNA methylation patterns within the gene′s promoter region, thereby silencing its transcriptional activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid might decrease OR10Q1 expression by binding to retinoic acid receptors that interact with the promoter region of OR10Q1, suppressing its transcription. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin may downregulate OR10Q1 expression by increasing intracellular cAMP, which could activate protein kinase A (PKA) and lead to phosphorylation of transcription factors that repress OR10Q1 gene transcription. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate might reduce OR10Q1 expression by inhibiting histone deacetylases, leading to hyperacetylation of histones and the suppression of transcriptionally active chromatin at the OR10Q1 locus. | ||||||
3,3′-Diindolylmethane | 1968-05-4 | sc-204624 sc-204624A sc-204624B sc-204624C sc-204624D sc-204624E | 100 mg 500 mg 5 g 10 g 50 g 1 g | $36.00 $64.00 $87.00 $413.00 $668.00 $65.00 | 8 | |
DIM could decrease OR10Q1 expression by altering estrogen receptor-mediated transcriptional repression mechanisms that target the OR10Q1 gene promoter. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $62.00 $260.00 | 21 | |
Ketoconazole might inhibit OR10Q1 expression by reducing the synthesis of steroid hormones that are potential upstream regulators of OR10Q1 gene transcription. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
BPA could decrease the expression of OR10Q1 by interfering with the hormonal signaling pathways that are essential for the maintenance of OR10Q1 gene transcription. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone might suppress OR10Q1 expression by activating glucocorticoid receptors that bind to glucocorticoid response elements in the OR10Q1 promoter region, leading to transcriptional repression. | ||||||